Dr. Dhoot is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
525 E Micheltorena St
Ste A
Santa Barbara, CA 93103Phone+1 805-963-1648Fax+1 805-965-5214
Education & Training
- Cleveland Clinic FoundationFellowship, Surgical Retina and Vitreous, 2010 - 2012
- Oregon Health & Science University (OHSU Health)Residency, Ophthalmology, 2007 - 2010
- Legacy Health/Emanuel Medical CenterInternship, Internal Medicine, 2006 - 2007
- Oregon Health and Science University School of MedicineClass of 2006
Certifications & Licensure
- OR State Medical License 2009 - Present
- CA State Medical License 2012 - 2025
- OH State Medical License 2010 - 2013
- American Board of Ophthalmology Ophthalmology
Clinical Trials
- Analysis of Aqueous and Vitreous Humor Start of enrollment: 2015 Jul 01
Publications & Presentations
PubMed
- 213 citationsSystemic Pharmacokinetics And Pharmacodynamics Of Intravitreal Aflibercept, Bevacizumab, And RanibizumabRobert L. Avery, Alessandro A. Castellarin, Nathan C. Steinle, Dilsher S. Dhoot, Dante J. Pieramici
Retina. 2017-10-01 - 70 citationsKESTREL and KITE: 52-Week Results From Two Phase III Pivotal Trials of Brolucizumab for Diabetic Macular Edema.David M Brown, Andrés Emanuelli, Francesco Bandello, Jose Juan Escobar Barranco, João Figueira
American Journal of Ophthalmology. 2022-06-01 - 279 citationsSystemic pharmacokinetics following intravitreal injections of ranibizumab, bevacizumab or aflibercept in patients with neovascular AMDRobert L. Avery, Alessandro A. Castellarin, Nathan Steinle, Dilsher S. Dhoot, Dante J. Pieramici
The British Journal of Ophthalmology. 2014-12-01
Press Mentions
- Oculis Accelerates Enrollment for Phase 3 DIAMOND Trials of OCS-01 Eye Drops in DMEOctober 21st, 2024
- Research Promises Better Diabetic Retinopathy ManagementAugust 16th, 2024
- Aflibercept Shows Macular Perfusion Gains in VISTA SubanalysisMarch 7th, 2018
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: